Mikhail Blagosklonny in one of his publications on Oncotarget stated that 2014 was a year of jubilee after it ended on such a high note. Everolimus was tested and found to be a miracle worker as it boosted the immunity of aging people. This was a turning point in research and a new page in prolonging the lives of people. This had been predicted over 10 years before its success. The research has been an ongoing process and it was believed that with age, the functionality of the body was deteriorating and damage to the molecules was increasing. With the new discovery of doses of Everolimus or some form of rapamycin, the health cycle of an average human being has been increased.Rapamycin is the miracle everyone had been waiting for as it boosts immunity and also improves the general health of old people. In 2006, the rapamycin had already been approved for clinical use for age related diseases, cancer, autoimmunity, metabolic disorders and cardiovascular diseases. It has been tested and confirmed that it is non-toxic and safe for daily use, therefore, encourages immunity instead of suppressing it.
Mikhail Blagosklonny studies aging symptoms and cancer. He is a professor of Oncology. He is the founder of the above hypothesis in aging and the possible use of rapamycin to cure cancer and extend life cycles through healthy living. He has earned himself a title of the most active and passionate advocate of rapamycin as a long term solution for health related problems associated with age.Mikhail Blagosklonny urges that the TOR-centric model promotes long life through a decrease of sensitivity through the reduction of pathway signaling of PI3K/Akt/mTOR. This pathway is helpful for the growth and development of a human being immunity especially since growing old is associated with the development of harmful growth. The model increases the longevity of the genes. When the cell cycle comes to a halt, there is a promotion of growth that causes senescence. This suppresses the tumors and this is what promotes the cure for cancer and other diseases.
Suren Sehgal has also played a part in the formation of the anti-aging drug that is been used today. He had been studying the bacterium that is used in the creation of the anti-aging drug for years in Montreal. Mikhail Blagosklonny accomplished what Suren had originally begun and is now the renowned advocate for the rapamycin solution to age related diseases. Mikhail Blagosklonny has studied, published and given talks related to this drug at an international level. He is a convincing figure in the adoption of this medicine as a solution to the age related problems and chronic diseases such as cancer. Mikhail studied at the First Pavlov State Medical University of St. Petersburg and has qualifications in internal medicine, cardiology, and experimental medicine. He has used his knowledge in his research and has come up with over 270 publications that explain the different scenarios of his findings. Mikhail Blagosklonny has played a big part in improving the lives of many people in the old age globally.